BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 28332312)

  • 21. Development of Monoclonal Antibody LpMab-10 Recognizing Non-glycosylated PLAG1/2 Domain Including Thr34 of Human Podoplanin.
    Ogasawara S; Oki H; Kaneko MK; Hozumi Y; Liu X; Honma R; Fujii Y; Nakamura T; Goto K; Takagi M; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2015 Oct; 34(5):318-26. PubMed ID: 26492619
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel knock-in mouse model for the evaluation of the therapeutic efficacy and toxicity of human podoplanin-targeting agents.
    Ukaji T; Takemoto A; Shibata H; Kakino M; Takagi S; Katayama R; Fujita N
    Cancer Sci; 2021 Jun; 112(6):2299-2313. PubMed ID: 33735501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of Monoclonal Antibody LpMab-7 Recognizing Non-PLAG Domain of Podoplanin.
    Oki H; Kaneko MK; Ogasawara S; Tsujimoto Y; Liu X; Sugawara M; Takakubo Y; Takagi M; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2015 Jun; 34(3):174-80. PubMed ID: 26090595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of Sensitive Monoclonal Antibody PMab-2 Against Rat Podoplanin.
    Oki H; Honma R; Ogasawara S; Fujii Y; Liu X; Takagi M; Kaneko MK; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2015 Dec; 34(6):396-403. PubMed ID: 26683179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Establishment of Novel Monoclonal Antibody PMab-32 Against Rabbit Podoplanin.
    Honma R; Fujii Y; Ogasawara S; Oki H; Liu X; Nakamura T; Kaneko MK; Takagi M; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2016 Feb; 35(1):41-7. PubMed ID: 26788987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel targeting therapy of malignant mesothelioma using anti-podoplanin antibody.
    Abe S; Morita Y; Kaneko MK; Hanibuchi M; Tsujimoto Y; Goto H; Kakiuchi S; Aono Y; Huang J; Sato S; Kishuku M; Taniguchi Y; Azuma M; Kawazoe K; Sekido Y; Yano S; Akiyama S; Sone S; Minakuchi K; Kato Y; Nishioka Y
    J Immunol; 2013 Jun; 190(12):6239-49. PubMed ID: 23690472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epitope Analysis of an Antihorse Podoplanin Monoclonal Antibody PMab-219.
    Kato Y; Sayama Y; Sano M; Kaneko MK
    Monoclon Antib Immunodiagn Immunother; 2019 Dec; 38(6):266-270. PubMed ID: 31638470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Humanized and Defucosylated Antibody against Podoplanin (humLpMab-23-f) Exerts Antitumor Activities in Human Lung Cancer and Glioblastoma Xenograft Models.
    Suzuki H; Ohishi T; Kaneko MK; Kato Y
    Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibody-Drug Conjugates Using Mouse-Canine Chimeric Anti-Dog Podoplanin Antibody Exerts Antitumor Activity in a Mouse Xenograft Model.
    Kato Y; Ito Y; Ohishi T; Kawada M; Nakamura T; Sayama Y; Sano M; Asano T; Yanaka M; Okamoto S; Handa S; Komatsu Y; Takei J; Kaneko MK
    Monoclon Antib Immunodiagn Immunother; 2020 Apr; 39(2):37-44. PubMed ID: 32182186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of hematogenous metastasis by neutralizing mice and its chimeric anti-Aggrus/podoplanin antibodies.
    Nakazawa Y; Takagi S; Sato S; Oh-hara T; Koike S; Takami M; Arai H; Fujita N
    Cancer Sci; 2011 Nov; 102(11):2051-7. PubMed ID: 21824222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Establishment of Monoclonal Antibody PMab-202 Against Horse Podoplanin.
    Furusawa Y; Yamada S; Itai S; Sano M; Nakamura T; Yanaka M; Handa S; Mizuno T; Maeda K; Fukui M; Harada H; Kaneko MK; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2018 Nov; 37(5):233-237. PubMed ID: 30362932
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistochemical Analysis of Inflammatory Rheumatoid Synovial Tissues Using Anti-Human Podoplanin Monoclonal Antibody Panel.
    Suzuki T; Takakubo Y; Oki H; Liu X; Honma R; Naganuma Y; Goodman SB; Kaneko MK; Kato Y; Takagi M
    Monoclon Antib Immunodiagn Immunother; 2018 Feb; 37(1):12-19. PubMed ID: 29377768
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional characterization of recombinant snake venom rhodocytin: rhodocytin mutant blocks CLEC-2/podoplanin-dependent platelet aggregation and lung metastasis.
    Sasaki T; Shirai T; Tsukiji N; Otake S; Tamura S; Ichikawa J; Osada M; Satoh K; Ozaki Y; Suzuki-Inoue K
    J Thromb Haemost; 2018 May; 16(5):960-972. PubMed ID: 29488681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PMab-219: A monoclonal antibody for the immunohistochemical analysis of horse podoplanin.
    Furusawa Y; Yamada S; Itai S; Nakamura T; Yanaka M; Sano M; Harada H; Fukui M; Kaneko MK; Kato Y
    Biochem Biophys Rep; 2019 Jul; 18():100616. PubMed ID: 30766925
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Establishment of a monoclonal antibody PMab-225 against alpaca podoplanin for immunohistochemical analyses.
    Kato Y; Furusawa Y; Yamada S; Itai S; Takei J; Sano M; Kaneko MK
    Biochem Biophys Rep; 2019 Jul; 18():100633. PubMed ID: 30997422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors.
    de Weers M; Tai YT; van der Veer MS; Bakker JM; Vink T; Jacobs DC; Oomen LA; Peipp M; Valerius T; Slootstra JW; Mutis T; Bleeker WK; Anderson KC; Lokhorst HM; van de Winkel JG; Parren PW
    J Immunol; 2011 Feb; 186(3):1840-8. PubMed ID: 21187443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Epitope of PMab-210 Is Located in Platelet Aggregation-Stimulating Domain-3 of Pig Podoplanin.
    Kaneko MK; Sayama Y; Sano M; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2019 Dec; 38(6):271-276. PubMed ID: 31663836
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blocking podoplanin suppresses growth and pulmonary metastasis of human malignant melanoma.
    Xu M; Wang X; Pan Y; Zhao X; Yan B; Ruan C; Xia L; Zhao Y
    BMC Cancer; 2019 Jun; 19(1):599. PubMed ID: 31208371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet-activating factor podoplanin: from discovery to drug development.
    Takemoto A; Miyata K; Fujita N
    Cancer Metastasis Rev; 2017 Jun; 36(2):225-234. PubMed ID: 28674748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antipodocalyxin Antibody chPcMab-47 Exerts Antitumor Activity in Mouse Xenograft Models of Colorectal Adenocarcinomas.
    Kaneko MK; Kunita A; Yamada S; Nakamura T; Yanaka M; Saidoh N; Chang YW; Handa S; Ogasawara S; Ohishi T; Abe S; Itai S; Harada H; Kawada M; Nishioka Y; Fukayama M; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2017 Aug; 36(4):157-162. PubMed ID: 28665782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.